CRL

CHARLES RIVER LABORATORIES INTERNATIONAL INC

Healthcare | Mid Cap

$2.22

EPS Forecast

$991.1

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

$2.22

Revenue Forecast:

$991.1

EPS Surprise Forecast:

$0.210

Revenue Surprise Forecast:

$7

Post-release price volatility - High

Post-release Overnight Move:

±7.6%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

86%

Probability of beating revenue consensus:

74%

Probability of beating both EPS & revs consensus:

67%

Probability of missing both EPS & revs consensus:

8%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

1

Beta (β)

Forward Looking Beta (β):

1.58

Earnings volatility

EPS standard deviation:

$0.42

Revenue standard deviation:

$25

As % of share price:

0.27% MEDIUM

As % of market cap:

0.33% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$2.78

Revenue 95th %ile:

$1,025

EPS 75th %ile:

$2.37

Revenue 75th %ile:

$1,000

EPS 25th %ile:

$2.10

Revenue 25th %ile:

$983

EPS 5th %ile:

$1.78

Revenue 5th %ile:

$963

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

44% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

36% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$18

Bid-ask per Share:

$0.28